2,154 reports of this reaction
3.0% of all HUMAN IMMUNOGLOBULIN G reports
#4 most reported adverse reaction
HEADACHE is the #4 most commonly reported adverse reaction for HUMAN IMMUNOGLOBULIN G, manufactured by ADMA Biologics, Inc.. There are 2,154 FDA adverse event reports linking HUMAN IMMUNOGLOBULIN G to HEADACHE. This represents approximately 3.0% of all 73,013 adverse event reports for this drug.
Patients taking HUMAN IMMUNOGLOBULIN G who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for HUMAN IMMUNOGLOBULIN G, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for HUMAN IMMUNOGLOBULIN G:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 2,154 FDA reports for HUMAN IMMUNOGLOBULIN G. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.0% of all adverse event reports for HUMAN IMMUNOGLOBULIN G, making it a notable side effect.
If you experience headache while taking HUMAN IMMUNOGLOBULIN G, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.